This Cabinet paper sought agreement to pre-commit funds against Budget 2024 so that Pharmac could continue to fund medicines at planned level from 1 July 2024, when time-limited funding approved in 2022 and 2023 ended. The proposal contributes to the Government priority to deliver better public services. It addresses the coalition health commitments by:
- helping to increase Pharmac’s budget every year
- creating a baseline to work towards giving Kiwis access to 13 more cancer
treatments - providing a strong foundation to work towards updating Pharmac’s decision making model to ensure it appropriately takes patient voice into account.
These documents have been proactively released by the Ministry of Health on behalf of the Associate Minister of Health, Hon David Seymour.
Title of Cabinet paper:
- Investment to continue access to medicines
Title of minute:
- Report of the Cabinet Expenditure and Regulatory Review Committee: Period ended 1 March 2024 (CAB-24-MIN-0064)
- Cabinet Expenditure and Regulatory Review Committee Minute of Decision: Investment to Continue Access to Medicines (EXP-24-MIN-0004)
Some parts of this information release would not be appropriate to release and, if requested, would be withheld under the Official Information Act 1982 (the Act). Where this is the case, the relevant sections of the Act that would apply have been identified. Where information has been withheld, no public interest has been identified that would outweigh the reasons for withholding it.
Key to redaction codes:
- Out of scope.
- S 9(2)(j) to enable a Minister of the Crown or any public service agency or organisation holding the information to carry on, without prejudice or disadvantage, negotiations (including commercial and industrial negotiations).
